Awshad, a pioneering Indian medical cannabis wellness startup, has announced a significant dual milestone: achieving profitability in the fiscal year 2025 and launching its most potent product to date, a 6500mg CBD oil. This strategic move marks the company’s fourth anniversary and solidifies its position as one of the first homegrown players in India’s rapidly expanding medical cannabis wellness industry to reach financial success.
Founded in 2021 by Shivam Singhee and Richa Jaggi, Awshad emerged with a vision to revolutionize the wellness landscape in India by harnessing the therapeutic potential of cannabis-based products. At a time when the concept of medical cannabis was largely foreign in the country, the co-founders believed in its power to redefine health and well-being. Their perseverance has paid off, with the company now boasting over 10,000 customers and achieving a remarkable 20x growth since its inception.
A New Frontier in Potency: The 6500mg CBD Oil
The centerpiece of Awshad’s latest announcement is the launch of its 6500mg CBD oil, the strongest formulation ever introduced by the brand. This high-strength oil is specifically designed to offer relief for a range of severe health conditions, including chronic pain, cancer-related symptoms, epilepsy, acute anxiety, and insomnia. The development of this product underscores Awshad’s commitment to pushing the boundaries of cannabis-based wellness medicine in India and providing advanced solutions for those in need.
Profitability: A Testament to Market Trust and Innovation
Achieving profitability in FY25 is a crucial validation for Awshad, confirming its robust product-market fit and the deep trust it has cultivated among consumers. This financial stability is particularly noteworthy for a startup operating in a nascent and often stigmatized industry. It not only strengthens Awshad’s credibility among future investors but also reassures its growing customer base of the brand’s enduring quality and reliability. The company’s success is further attributed to its educational marketing strategies and innovative approach, which have helped navigate the challenges and myths surrounding cannabis products.
The Growing Indian Cannabis Wellness Market
Awshad’s achievements are unfolding against the backdrop of a burgeoning Indian cannabis market. Projections indicate substantial growth, with the market valued at USD 1.3 billion in FY2024 and expected to reach USD 4.7 billion by FY2032, growing at a compound annual growth rate of 17.34%. This expansion is fueled by several factors, including increasing consumer awareness, the growing acceptance of cannabis-based therapies for pain management and chronic diseases, supportive governmental policies, and a clearer regulatory framework, especially under the Ayush ministry for Ayurvedic cannabis products.
The rise of direct-to-consumer (D2C) brands, like Awshad, is a significant trend. These brands are making cannabis-based wellness products more accessible, offering them in various formats such as oils, tinctures, capsules, and gummies. The demand for such new cannabis products is driven by a desire for holistic, non-invasive health alternatives.
Future Outlook and Brand Expansion
Looking ahead, Awshad aims to further strengthen its position in the wellness market by expanding its product offerings, which already include CBD oils, capsules, mushroom supplements, gummies, and pet products. The company is keen on scaling its operations and fostering collaborations with healthcare professionals, researchers, and regulators to normalize CBD-based wellness solutions and make them mainstream. Awshad’s vision extends to making CBD-based wellness accessible, affordable, and acceptable to the masses, cementing its reputation as one of India’s most trusted cannabis wellness brands.
The brand’s journey from a niche startup to an established player, now profitable and launching its most potent product yet, signals a transformative phase for Awshad and the broader Indian medical cannabis industry.
